Corporate ActionJul 14, 2026, 05:31 PM
Antiaging Quantum Living Authorizes 6 Billion Shares, Shifts Business
AI Summary
Antiaging Quantum Living Inc. filed its 10-K, announcing a significant corporate action to increase authorized common stock from 30 million to 6 billion shares, categorized into five classes. The company also detailed a strategic shift in its business model, moving from online advertising and technical support to proprietary health products and therapy services. For the fiscal year ended March 31, 2026, revenue increased to $1.03 million, up 26.47%, but net loss widened to $837,646. The company issued a going concern warning due to negative financial trends and reliance on shareholder funding.
Key Highlights
- Authorized common stock increased from 30 million to 6 billion shares.
- Business model shifted to proprietary health products and therapy services.
- FY26 revenue increased 26.47% to $1,034,385.
- FY26 net loss widened 16.27% to $837,646.
- Gross profit increased to $702,123 (67.9% margin) in FY26.
- Company issued a going concern warning due to negative financial trends.
- 4,280,340 Class A shares issued from debt conversion in November 2025.
- Aggregate market value of non-affiliate common equity was $779,500 as of Sep 30, 2025.
Price Impact